Autologous stem cell transplant for AL amyloidosis patients aged 70 to 75

Autologous stem cell transplantation has been used in treatment for AL amyloidosis for over two decades and generally reserved for patients younger than 70 years of age. Herein we report on outcomes of ASCT in a cohort of patients with AL amyloidosis aged 70 years or older. Between August of 2002 an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Sidiqi, M Hasib, Aljama, Mohammed A., Muchtar, Eli, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Leung, Nelson, Gonsalves, Wilson I., Kapoor, Prashant, Kourelis, Taxiarchis V., Hogan, William J., Kumar, Shaji K., Gertz, Morie A.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239955/
https://ncbi.nlm.nih.gov/pubmed/29933071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.06.017
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items